Financial statements Biopoint M.jankowski M.niewiadomska
Balance sheet data of BIOPOINT M.JANKOWSKI M.NIEWIADOMSKA
|
Year
|
2021
|
2023
|
|---|---|---|
| Total assets | 16 930 886,84 | 18 469 430,53 |
| A. Fixed assets | 7 241 990,31 | 7 852 589,40 |
| B. Current assets | 9 688 896,53 | 10 616 841,13 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 16 930 886,84 | 18 469 430,53 |
| A. Equity | 15 687 282,78 | 15 308 733,25 |
| B. Liabilities and provisions for liabilities | 1 243 604,06 | 2 137 785,76 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 335 355,85 | 1 207 117,11 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.